Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 15, 2014 - Issue 3-4
Submit an article Journal homepage
123
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Record linkage between hospital discharges and mortality registries for motor neuron disease case ascertainment for the Spanish National Rare Diseases Registry

Elena RuizDepartment of Epidemiology, La Rioja Regional Authority, Logroño, SpainCorrespondence[email protected]
,
Enrique Ramalle-GómaraDepartment of Epidemiology, La Rioja Regional Authority, Logroño, Spain
,
Carmen QuiñonesDepartment of Epidemiology, La Rioja Regional Authority, Logroño, Spain
& On Behalf of The spain Rdr Working Group
Pages 275-278 | Received 28 Nov 2013, Accepted 28 Jan 2014, Published online: 18 Mar 2014

References

  • Talbot K. Motor neuron disease. Postgrad Med J. 2002; 78:513–9.
  • Gordon PH. Amyotrophic Lateral Sclerosis: An update for 2013. Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis. 2013;4:295–310.
  • Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population based registries. Biochim Biophys. Acta BBA – Mol Basis Dis. 2006;1762:1150–7.
  • Doyle P, Brown A, Beral V, Reeves G, Green J. Incidence of and risk factors for motor neuron disease in UK females: a prospective study. BMC Neurol. 2012;12:25.
  • Marin B, Couratier P, Preux P-M, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence?Neuroepidemiology. 2011;36:29–38.
  • Alonso V, Villaverde-Hueso A, Hens MJ, Morales-Piga A, Abaitua I, de la Paz MP. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990–2005). Amyotroph Lateral Scler. 2011;12:192–8.
  • Spanish Rare Diseases Registries Research Network- SpainRDR [cited 2013 Nov 15]. Available from: https://spainrdr.isciii.es/en.
  • Rivero A. The Minimum Data Set in NHS: Beginnings and current development]. Fuentes Estadísticas. 2000;49:18–9.
  • Preux P-M, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, et al. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000; 53:1025–9.
  • Denis A, Mergaert L, Fostier C, Cleemput I, Simoens S. A comparative study of European rare disease and orphan drug markets. Health Policy Amst Neth. 2010;97:173–9.
  • Dodge JA, Chigladze T, Donadieu J, Grossman Z, Ramos F, Serlicorni A, et al. The importance of rare diseases: from the gene to society. Arch Dis Child. 2011;96:791–2.
  • Alonso V, Villaverde-Hueso A, Hens M, Morales-Piga A, Abaitua I, Posada de la Paz M. Public health research on rare diseases. Georgian Med News. 2011;4:11–6.
  • Nagel G, Unal H, Rosenbohm A, Ludolph AC, Rothenbacher D, ALS Registry Study Group. Implementation of a population based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) registry Swabia. BMC Neurol. 2013;13:22.
  • Fang F, Al-Chalabi A, Ronnevi L-O, Turner MR, Wirdefeldt K, Kamel F, et al. Amyotrophic lateral sclerosis and cancer: a register based study in Sweden. Amyotroph Lateral Scler Frontal Lobar* Degener. 2013;14:362–8.
  • Rooney J, Byrne S, Heverin M, Corr B, Elamin M, Staines A, et al. Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995 to 2010. PloS One. 2013;8:e74733.
  • Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, et al. The association between ALS and population density: a population based study. Amyotrophic Lateral Sclerosis Official Publication, World Federation Research Group Motor Neuron Disorders. 2010;11:435–8.
  • Chiò A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, et al. ALS clinical trials: do enrolled patients accurately represent the ALS population?Neurology. 2011;77:1432–7.
  • Kurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry. 2009;80:84–7.
  • Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population based registries. Biochim Biophys Acta. 2006; 1762:1150–7.
  • Maxwell R, Wells C, Verne J. Under-reporting of progressive supranuclear palsy. Lancet. 2010;376:2072.
  • Yeo L, Lynch C, Hardiman O. Validating population based registers for ALS: how accurate is death certification?J Neurol. 2010;257:1235–9.
  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.